Ghofrani H, Simonneau G, D'Armini AM, et al. Efficacy and Safety of Macitentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from the Randomized Controlled MERIT Study. ATS 2017, A7601.
Longkanker vroeg opsporen om de overlevingskans (sterk) te verhogen
dec 2019 | Immuuntherapie, Longoncologie